Marshall Wace’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,869,340
| Closed | -$76.4M | – | 2897 |
|
|
2024
Q2 | $76.4M | Buy |
1,869,340
+647,074
| +53% | +$26.5M | 0.1% | 178 |
|
|
2024
Q1 | $51.7M | Buy |
1,222,266
+909,304
| +291% | +$38.4M | 0.08% | 219 |
|
|
2023
Q4 | $13.3M | Buy |
+312,962
| New | +$13.3M | 0.02% | 509 |
|
|
2021
Q2 | – | Sell |
-23,597
| Closed | -$324K | – | 2691 |
|
|
2021
Q1 | $324K | Sell |
23,597
-44,175
| -65% | -$607K | ﹤0.01% | 1795 |
|
|
2020
Q4 | $1.12M | Buy |
+67,772
| New | +$1.12M | 0.01% | 1048 |
|